Veröffentlichungen Dr. med. Wolfgang März seit 1993


Nitschke-Gérard C.1, Keller-Matschke K.1, März W.J.1; A case of visceral leishmaniasis in a patient with rheumatoid arthritis and no recent stay in a region endemic for leishmaniasis. DGHO 2013 (Vienna, Austria) Abstract Nr. A-593-0038-00480 - Poster

März, W., Grauer, S., Nitschke-Gérard, C., Zink, M., Damm, V., Scharf, T., Grauer, W., Treiber, G.; Successful Antiangiogenic Therapy with Bevacizumab (off label) after Failure of Thalidomide in a Patient with Hereditary Hemorhagic Teleangiectasia and Transfusion Dependent Gastrointestinal Blood Loss. DGHO 2012 Basel Switzerland - oral presentation

1Maerz W.J., 1Conradi I., 1Lorenz I., 1Heindel  S., 1Zebhauser  R., 2Truemper L. , 1Kempf  B.; High Incidence of  Pneumocystis Jirovecii Pneumonia with CHOP+Rituximab Therapy  for malignant B –NHL:  A Call  for Chemoprophylaxis. DGHO 2008 (Vienna, Austria) - Poster

Klaus Mross, Thomas Gierlich, Brigitte Häring, Wolfgang März, Clemens Unger; Clinical and pharmacokinetic study with liposomal doxorubicin (DL-1) in patients with advanced metastatic cancer- results from a phase-I study Int’l JclinPharmacolTherap 40(8): 387-388 2002

W. März W. Dengler S Fuxius D Semsek C Unger K Mross; Evaluation of a five day continuous high dose 5-FU constant rate infusion in patients with metastatic colon cancer; Abstract S0236P-1; "4. Jahres-tagung Deutsche Krebsgesellschaft" Berlin 2000

Gernot Georg Hartung, Klaus Mross, Max E Scheulen, Paul Kremer, W. Maerz, D. Borquez, Cornelia Schmidt, Gerd Stehle, Zdenek Spacek, Clemens Unger, Ruediger Hehlmann, Wolfgang Queisser; Phase I Study of Methotrexate-Albumin in a Bi-Weekly Intravenous Regimen in Cancer Patients; Proc.ASCO 2000 abstract # 847

Klaus Mross, Thomas Gierlich, Gerhild Ziegler-Widmer, Brigitte Häring, Wolfgang März, Uwe Sauer, Hansjörg Eibl, Clemens Unger; Clinical phase-I and pharmacokinetic study with liposomal doxorubicin (DL-1) in patients with advanced metastatic cancer.Annals of Oncology, Vol 11, Suppl.4 : 137 abstract #624P October 2000

K Mross W. März; Klinische Studien: Fundament einer Evidenz-basierten Onkologie - Bestandsaufnahme und Zukunft im Zeitalter des Internet; Onkologie 2001, 24:S1:24-34.

März W, Unger C.; [Asparagus in asparaginase therapy]?; Med Monatsschr Pharm. 1999 Dec;22 (12):393

W. März, C Unger K Mross; Chronopharmakologische Optimierung der Chemo-therapie bei GI-Tumoren (Übersichtsartikel); Klinikarzt 28(10) : 17-21 1999

Nason-Burchenal K., März W.J., Abanell J., Allopenna J., Martin P., Moore MAS., Dmitrovsky E. Comrnon; Defects of Different Retinoic Acid Resistant Promyelocytic Leukemia Cells are Persistent Telomerase Activity and Nuclear Body Disorganisation. Differentiation 161:321-331 1997

Kornacker M. , März W.J., v. Kalle C., Ehlers N. A.,Jox A. , Diehl V.,Wolf J.; Detection of Creatine kinase Overexpression in a Hodgkin - Reed Sternberg Cell Line by differential display. Blood 88/10 S1  #3467 1996

März W.J.,Baselga J., Reuter V., Mellado B., MyersM.L., Bosl G.J., Spinella M.J., Dmitrovski E. FGF-4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Oncogene 17(6):761- 767 1998

Nason-Burchenal K., März W.J., Abanell J., Allopenna J., Martin P., Moore MAS., Dmitrovsky E.; Common Defects of Different Retinoic Acid Resistant Promyelocytic Leukemia Cells are Persistent Telomerase Activity and Nuclear Body Disorganisation. Differentiation 161:321-331 1997

Winkler U Rieder H März W .J. Draube A. Franzen B Schmitz S Diehl V. Rehder H Engert A.; Refractory acute myeloid leukemia with complex chromosomal aberrations in a patient with Rothmund-­Thomson Syndrome; AnnalsHematol73 SII:A101 #402 1996

Moasser MM Khoo K-S. März W.J. Zelenetz A Dmitrovsky E; Derivation and Characterisation of retinoid-resistant human embryonal carcinoma cells. Differentiation 60:251-257 1996

März WJ. ,Kube D. ,Diehl V., Tesch H.; ATRA Target Gene Mapping by Differential Display PCR in Human Promyelocytic Leukemia Cells; Blood 86/10 S1 :647 #2682 1995

März WJ. , deBlasio A., Tesch H.,Diehl V ., Dmitrovsky E.; Molecular Analysis of Acute Promyelocytic Leukemia: RT -PCR of PML-RAR a and in-vitro Proliferation- And Differentiation-Assays. Onkologie 18s2:142, A483 1995

März WJ. , Nason-Burchenal K. , Dmitrovsky E.,Diehl V. , Tesch H.; M-RNA Phenotyping by 'differential Display' PCR for the Identification of Genes regulated during all­trans Retinoic Acid [ATRA] mediated Leukemia Cell Differentiation in-vitro. Onkologie 18s2 : 142, A484 1995

März WJ. , Kube D., Diehl V., Tesch H.; 'Differential Display' PCR identifies Candidate Genes Regulated During all-trans Retinoic Acid Mediated Terrninal Granulocytic Differentiation Of HL6O Cells in vitro. Exp Hematol23:783, A149 1995

Maerz WJ., Baselga J., Dmitrovsky E. Overexpression of FGF-4 promotes tumorigenicity without blocking retinoic acid-mediated human teratocarcinoma differentiation. Proc AACR 35:A3509 1994

Moasser M., Maerz WJ., Miller WHjr., Dmitrovsky E.; ATRA resistance in human teratocarcinomas is linked to aberrant RAR-gamma expression. Proc AACR 34:A283 1993

Miller WHjr., Maerz WJ., Kurie J., Moy D., Baselga J., Lucas DA., Grippo JF., Masui H., Dmitrovsky E. All-trans-retinoic acid and hexamethylene-bis-acetamide [HMBA] regulate TGF-a and HST -l/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas. Differentiation 55: 145-152 1994

Baselga J., Maerz WJ., Moy D., Miller WHjr., Castro L., Reuter VE., Yao TJ., Masui H., Dmitrovsky E. Overexpression of transforrning growth factor alpha antagonizes the antitu-morigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell. Oncogene 8:3257-63 1993